Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new drug, TG4050, for safety and effectiveness in treating squamous cell carcinoma of the head and neck.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any uncontrolled illnesses.I am 18 years old or older.I am fully active or restricted in physically strenuous activity but can do light work.I have previously received immunotherapy for cancer.My cancer is not from the skin, salivary gland, or sinuses and is not squamous cell carcinoma.My blood, liver, and kidney functions are all within normal ranges.I have tested positive for HIV/AIDS.You have taken another experimental drug within the last 30 days before starting treatment with TG4050.I have had cancer other than the one being studied in this trial.I have a history of Hepatitis B or C.I am currently receiving treatment for another cancer.I have been newly diagnosed with advanced cancer in my mouth or throat.My primary cancer is completely gone after treatment.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Arm A : Early study treatment initiation
- Group 2: Arm B: Study treatment initiation at recurrence
Frequently Asked Questions
Has the FDA sanctioned TG4050 for public use?
"Our experts at Power gave TG4050 a rating of 1 as it is currently undergoing Phase 1 trials, which indicates there are limited data points evaluating its safety and efficacy."
Could you tell me if this research project is currently welcoming volunteers?
"According to the data posted on clinicaltrials.gov, this study is actively recruiting candidates and has been since December 12th 2019 with its most recent update occurring on November 5th 2021."
What is the scope of this research project in terms of participants?
"Affirmative. The details hosted on clinicaltrials.gov reveal that this medical trial, which was first advertised in December of 2019, is still seeking new enrollees. In total, 30 patients are being recruited from a single site."
Share this study with friends
Copy Link
Messenger